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Adhesion and motility of mammalian leu-
kocytes are essential requirements for
innate and adaptive immune defense
mechanisms. We show here that the
guanine nucleotide exchange factor
cytohesin-1, which had previously been
demonstrated to be an important compo-
nent of beta-2 integrin activation in lym-
phocytes, regulates the activation of the
small GTPase RhoA in primary dendritic
cells (DCs). Cytohesin-1 and RhoA are
bothrequired for the inductionofchemokine-
dependent conformational changes of the
integrin beta-2 subunit of DCs during
adhesion under physiological flow condi-
tions. Furthermore, use of RNAi in murine
bone marrow DCs (BM-DCs) revealed that
interference with cytohesin-1 signaling
impairs migration of wild-type dendritic
cells in complex 3D environments and in
vivo. This phenotype was not observed in
the complete absence of integrins. We
thus demonstrate an essential role of
cytohesin-1/RhoA during ameboid migra-
tion in the presence of integrins and
further suggest that DCs without inte-
grins switch to a different migration mode.
(Blood. 2009;113:5801-5810)
Introduction
Integrin-mediated adhesion is an essential function of most meta-
zoan cells, and plays a key role in, for example, organ development,
the maintenance of tissue architecture, blood clotting, and many
aspects of leukocyte biology. The mammalian integrin family
consists of 24 heterodimeric cell surface receptors that bear distinct
functional binding specificities for extracellular matrix proteins and
plasma membrane counterreceptors.1 Immune cells have highly
specific requirements for timing and location of cell-cell and
-matrix contacts, which need to be finely tuned to variable
conditions of homeostasis and inflammation.
An important hallmark of integrin function in the immune
system is the rapid adhesion of leukocytes to activated endothelia, a
process that is essential for immune cell egress from the vascula-
ture into either lymphoid organs or into infected tissues. To perform
such functions, integrins on leukocytes have to be activated by a
process that has been termed “inside-out” signaling. It is now
generally believed that integrins on circulating, resting leukocytes
are conformationally restricted, so that they normally cannot bind
to their protein ligands, such as ICAM-1 or VCAM-1. However, if
a leukocyte becomes tethered to an endothelial cell, for example,
by selectin-mediated adhesive “rolling,” immune cell chemokine
receptors such as CCR7 or CXCR4 may be activated by chemo-
kines present on the activated vessel wall.2,3 This, in turn, results in
intracellular, heterotrimeric G-protein–coupled signal transduction,
which enables very fast conformational changes and ligand binding
of cell surface integrins, resulting in a robust firm adhesion, the
so-called integrin-mediated leukocyte “arrest.”3 Shear forces im-
posed by the blood flow apparently play an important role in the
regulation of this process.4 The mode of activation of immune cell
integrins is incompletely understood. Several intracellular proteins
that directly or indirectly interact with the cytoplasmic domains of
the leukocyte-specific beta-2 integrins, such as LFA-1, have been
implicated in this function. These include the actin- and integrin-
binding protein talin, which is important for the general coupling of
integrin-mediated cell adhesion to the actin cytoskeleton,5-7 the
GTPase Rap17-9 and its effector proteins RAPL and RIAM,9-11 the
ADAP/Vav/SLP76 complex in T cells,12-14 the Rho GTPases
RhoA15 and CdC42,16 and, recently, the so-called kindlin
proteins.17,18
Our laboratory has identified the guanine nucleotide exchange
factor (GEF) for ADP-ribosylation factor (ARF) GTPases,
cytohesin-1, as an LFA-1 interacting protein. Cytohesin-1 binds
specifically to the cytoplasmic portion of the integrin beta-2
subunit CD18.19 In Jurkat T cells, overexpression of cytohesin-1
results in up-regulation of LFA-1 adhesion to ICAM-1, whereas the
expression of the isolated PH domain of cytohesin-1, which is
required for inositol-phospholipid–mediated membrane recruit-
ment of the protein, abrogates LFA-1 activation.20,21 Cytohesin-1
was also found to be an important regulator of beta-2 integrin–
mediated recruitment of monocytic cells to human endothelial cells
under physiological flow conditions.22 The precise mechanism of
integrin activation by cytohesin-1 is not understood but it involves
both direct interactions, possibly resulting in triggering conforma-
tional switches, and signal transduction through its GEF domain,
which activates ARF GTPases, a function that is important for cell
spreading.23
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Another important requirement for immune cell functionality is their
ability to rapidly move through complex environments in the intersti-
tium. So-called dendritic cells (DCs) of myeloid origin become acti-
vated by pathogen encounter in infected tissues through Toll-like
receptor and inflammatory cytokine signaling. During this process, DCs
“mature,” that is, they undergo massive changes in morphology that
enable their rapid motility. At the same time, DCs up-regulate surface
proteins that enable their trafficking to lymphoid organs, for example,
chemokine receptors such as CCR7, as well as costimulatory receptors
and MHC molecules that are required for proper T-cell activation by
DCs in secondary lymphoid organs. The importance of integrins in
coupling ECM recognition to cytoskeletal rearrangements in interstitial
immune cell migration has been subject to debate. Several years ago,
seminal work by Friedl et al24 suggested that integrins might not be
required for interstitial motility of T cells. Recently, an elegant study
published by Lämmermann et al,25 which used dendritic cells and
neutrophil granulocytes from mice that lack all integrins on the
leukocyte surface, showed that integrin-deficient immune cells appar-
ently migrate normally in vitro and in vivo. However, rapid interstitial
migration of these cells was shown to be dependent on rapid forward
flow of actin at the cell front, and on their capacity to deform organelles
such as the nucleus to “squeeze” through narrow passages in collagen/
matrix webs. This latter ability was dependent on intracellular signaling
pathways controlled by the GTPase RhoA.25
We show here that the ARF-GEF and beta-2 integrin binding
protein cytohesin-1 serves a novel, dual role in mediating dendritic
cell adhesion and migration, and the common denominator of both
functions is the positioning of the protein upstream of RhoA. The
expression of cytohesin-1 protein has been efficiently silenced by
RNAi in mature dendritic cells of both human and murine origin.
Interestingly, mature DCs are capable of activating their beta-2
integrins by chemokine signaling under physiological flow condi-
tions, a function that is linked to PI3-kinase and cytohesin-1–
mediated inside-out signal transduction. Furthermore, cytohesin-1
is shown for the first time to control DC migration in 3D collagen
gels, and to regulate mature DC migration in vivo by functioning
upstream of RhoA activation. Strikingly, cytohesin-1 is apparently
not required for 3D migration of integrin knockout DCs (quadruple
ablation of the integrin alpha-v, beta-1, beta-2, and beta-7 genes,
respectively25). These findings suggest that immune cell migration
may also be subclassified into distinct modes, and that the
integrin-dependent mode selectively requires the function of
cytohesin-1 upstream of RhoA.
Methods
Generation of human monocyte-derived DCs
See supplemental methods (available on the Blood website; see the
Supplemental Materials link at the top of the online article). Animal care
and experiments were done in compliance with institutional guidelines and
the German law for Welfare of Laboratory Animals. Isolation of primary
cells was approved by the University of Bonn ethics committee.
Generation of murine bone marrow–derived DCs
See supplemental methods.
Generation of integrin-deficient bone marrow–derived DCs
Generation of integrin alpha-v–, beta-1–, beta-2–, and beta-7–deficient
bone marrow–derived DCs (BM-DCs) has been described by Lämmermann
et al.25
Antibodies
The following monoclonal antibodies were used against the human
antigens: HLA-DR, CD80, CD86 (all from BD Pharmingen, San Diego,
CA), anti-CCR7 and anti-CXCR4 (both from R&D Systems, Minneapolis,
MN), anti-CD18 MHM23 (Dako, Carpinteria, CA). The 327C26,27 specific
for activated human CD18 epitopes was a gift from D. Staunton (Seattle,
WA). E. Kremmer (Munich, Germany) generated a rat monoclonal antibody
(7H2) against human cytohesin-1 as previously described23 and 2D7, which
also detects cytohesin. These monoclonal antibodies were against the
following mouse antigens: MHCII, CD80 (clone 16-10A1), CD86 (clone
B7-2; all from eBiosciences, San Diego, CA). These monoclonal antibodies
were against both human and mouse antigens: anti-RhoA (Santa Cruz
Biotechnology, Santa Cruz, CA) and anti-Rac (Chemicon, Temecula, CA).
For flow cytometry analysis, the following isotype-matched antibody
controls were used: rat IgGI PE (BD Pharmingen) and rat IgGI FITC (clone
eBRG1; eBiosciences).
Oligonucleotide sequences and plasmids
See supplemental methods.
siRNA transfections
Oligonucleotides (5 g siRNA against the target sequence of cytohesin-1;
10 g against the target sequence of RhoA or Rac1, respectively) were
transferred to a 4-mm cuvette (Bridge, Providence, RI) and incubated for 3
minutes with 4  106 immature DCs (imDCs) in 100 L Optimem
(Invitrogen, Frederick, MD) before electroporation in a Gene Pulser X cell
 CE module (Bio-Rad, Hercules, CA). Pulse conditions were square
wave, 1000 V, 2 pulses, and 0.5-ms pulse length. Forty-eight hours after
electroporation, imDCs were stimulated to mature (Document S1). Seventy-
two to 96 hours after electroporation, RNAi efficiency was tested using a
standard Western blot protocol and silenced mature DCs (mDCs) were used
for functional assays.
Transfection of monocyte-derived DCs with plasmid DNA
See supplemental methods.













Migration assay with GFP-transfected monocyte-derived
dendritic cells
See supplemental methods.
In vivo migration assays
See supplemental methods.
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3D collagen gel chemotaxis assay
3D chemotaxis assays were processed as described by Friedl et al24 with the
following modifications. Collagen I (Pure Col; Inamed, Fremont, CA) was
mixed with 0.7% sodium bicarbonate (Invitrogen) and 1  MEM (Sigma-
Aldrich, St Louis, MO) on ice. BM-DCs in VLE-RPMI/0.5% FCS were
carefully mixed with the collagen solution at a 2:1 ratio, resulting in gels
with a collagen concentration of 1.6 mg/mL and a final cell concentration of
1.5  106 cells/mL gel. Collagen–BM-DC mixtures were placed in custom-
made chemotaxis chambers and incubated at 37°C/5% CO2 for 90 minutes.
After collagen polymerization, 600 ng/mL CCL19 (R&D Systems) in
VLE-RPMI/0.5% FCS was added on top of the gel. Time-lapse series of
motile BM-DCs in 3D collagen gel were recorded using a fully automated
inverted TE Eclipse microscope (Nikon, Tokyo, Japan), equipped with a
10  phase-contrast objective (Nikon), motorized xyz-stage (Märzhäuser,
Wetzlar, Germany), a climate chamber (37°C/5% CO2 humidity), and a
CCD-1300 camera (Vosskühler, Osnabrücu, Germany). For every single
experiment 60 individual BM-DCs were tracked over 3 hours (5 minutes/
frame) using the manual tracking plug-in of ImageJ (National Institutes of
Health [NIH], Bethesda, MD). Subsequently, cell directionality, forward
migration index, and velocity were calculated and visualized as plots and
videos by analyzing the acquired data with the Chemotaxis and Migration




Statistical significance between data groups was determined by analysis of
variance (ANOVA) with the Instat software (GraphPad, San Diego, CA)
and considered to be significantly different at P values less than .05. The
P values are depicted as asterisks in the figures. *** indicates P value less
than .001; **, P value less than .01; and *, P value less than .05.
Results
Efficient RNAi of cytohesin-1 does not affect maturation of
human or murine dendritic cells
The mRNA of cytohesin-1 is up-regulated in human monocyte-
derived dendritic cells (Mo-DCs) upon maturation induced by
lipopolysaccharide (LPS) and TNF-.26 We performed Western
blot analysis to establish the up-regulation on the protein level
(Figure 1A). On day 7 after isolation of monocytes, expression of
cytohesin-1 was detectable in immature dendritic cells by the
specific anti–cytohesin-1 antibody 7H2. Incubation of the cells
with LPS and TNF- yielded a strong increase of cytohesin-1
expression, which reaches peak levels at day 9. The maturation of
DCs was determined by controlling the expression of the character-
istic markers HLA-DR, CD80, and CD86 by fluorescence-
activated cell sorting (FACS) analysis.
RNA interference can be used to specifically inhibit gene
expression and to analyze gene function.27 Using electroporation,
we silenced cytohesin-1 protein expression during maturation of
DCs. Compared with Mo-DCs that were transfected with a control
siRNA, RNAi of cytohesin-1 dramatically reduced specific protein
expression, as detected by Western blot analysis (Figure 1B). In
contrast to human Mo-DCs, cytohesin-1 is constitutively expressed
in murine BM-DCs (not shown). Nonetheless, RNAi-mediated
silencing of cytohesin-1 yielded a similar reduction of specific
protein expression in this cell type (Figure 1C).
To test whether RNAi of cytohesin-1 interferes with maturation
of DCs, we measured the cell surface expression of maturation
markers with the help of flow cytometry (FACS). Figure S9A
shows that maturation of Mo-DCs is not altered after transfec-
tion with a cytohesin-1–specific siRNA, compared with control
cells. Furthermore, we assessed potential effects of cytohesin-1
knockdown on the expression of CCR7 and CXCR4 on mature
Mo-DCs. CCR7 and CXCR4 are receptors for the chemokines
CCL19 and CXCL12, respectively, which are important media-
tors of mDC migration in vivo. As shown in Figure S9A, RNAi
of cytohesin-1 interfere neither with the expression of CCR7,
nor with that of CXCR4. Hence, the reduction of cytohesin-1
protein expression does not affect the cellular levels of a variety
of important surface proteins of mature Mo-DCs. Consistently,
RNAi of cytohesin-1 does not significantly affect maturation
marker expression of murine BM-DCs, compared with control
samples (Figure S9B).
Cytohesin-1 mediates chemokine-induced activation of CD18 in
mature Mo-DCs
We have previously shown that overexpressed cytohesin-1 colocal-
izes with CD18 in Jurkat cells and activates LFA-1 adhesion to
ICAM-1.23 Here, we demonstrate that endogenous cytohesin-1
colocalizes with the beta-2 integrin subunit CD18 in mature
Mo-DCs upon chemokine stimulation (Figure 2A). Immunofluores-
cence tracings reveal that endogenous cytohesin-1 is predomi-
nantly located in the cytoplasm in Mo-DCs. However, stimulation
of mature Mo-DCs with the chemokine CCL19 induces transloca-
tion of cytohesin-1 to the plasma membrane (Figure 2A middle
panel) where it remains colocalized with CD18 after antibody-
mediated clustering of the integrin (Figure 2A bottom panel). To
elucidate the functional significance of this finding, we analyzed
Figure 1. Cytohesin-1 is up-regulated in human Mo-DCs during maturation, and
is efficiently silenced by RNAi in both human and murine DCs. Western blot
analysis shows that cytohesin-1 expression is up-regulated in human monocyte-
derived dendritic cells (Mo-DCs) upon maturation induced by LPS (1 g/mL)/TNF
alpha (50 ng/mL; panel A lanes d8, d9, d10). Expression of cytohesin-1 is barely
detectable in immature dendritic cells (imDCs), but maturation results in a strong
increase of cytohesin-1 expression, reaching maximum levels at day 9 (A). Using
square wave electroporation, cytohesin-1 expression was efficiently silenced in
mature DCs. Western blot analysis shows that RNAi of cytohesin-1 reduces specific
protein expression 96 hours after electroporation in human Mo-DCs (B) or murine
bone marrow-derived DCs (BM-DCs, C).
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the affinity state of beta-2 integrins on mature Mo-DCs after
stimulation with CCL19. Chemokines induce a rapid affinity
increase of LFA-1, which is sufficient to cause an arrest of
circulating lymphocytes on endothelial cells.28 Integrin activation
is accompanied by conformational changes. The antibody 327C
may be used to report CD18 epitopes that are expressed only on
activated beta-2 integrins because 327C detects the high-affinity
state of LFA-1.29,30 Using this antibody, we performed FACS
staining of unstimulated and CCL19-stimulated mature Mo-DCs
(Figure 2B). Unstimulated Mo-DCs showed partial activation of
CD18, the level of which differed between cell donors (data not
shown). However, CCL19 strongly increased the expression of the
327C epitope in Mo-DCs, whereas RNAi of cytohesin-1 com-
pletely abrogates expression of this epitope (Figure 2B). To test
whether RNAi of cytohesin-1 reduces surface expression of CD18,
we also analyzed steady-state beta-2 integrin expression on Mo-
DCs, using antibody MHM23, which recognizes a constitutive
CD18 epitope. CD18 expression is not altered after RNAi of
cytohesin-1, compared with control cells (Figure 2B). Therefore,
cytohesin-1 is an important positive regulator of CD18 affinity in
mature Mo-DCs and mediates chemokine-induced inside-out acti-
vation of beta-2 integrins on this cell type.
Cytohesin-1 regulates adhesion of human and murine dendritic
cells
We then assessed static cell adhesion to ICAM-1 using cytohesin-1
knockdown Mo-DCs and control cells. Our results clearly establish
cytohesin-1 as an endogenous regulator of beta-2 integrin–
mediated adhesion, because RNAi of cytohesin-1 markedly re-
duced static adhesion of unstimulated and PMA-stimulated Mo-
DCs to ICAM-1 (Figure 2C). To test whether cytohesin-1 regulates
Figure 2. Cytohesin-1 (red fluorescence) colocalizes with CD18 (green fluorescence) and mediates both CD18 activation and adhesion. In contrast to unstimulated
mature Mo-DCs where cytohesin-1 (detected by mAb 7H2) localizes to the cytoplasm (A top panel), stimulation with 200 ng/mL CCL19 for 10 minutes induces translocation of
cytohesin-1 to the plasma membrane (A middle panel) where it colocalizes with beta-2 integrins, clustered by an anti-CD18 antibody (A bottom panel; bar represents 5 m). All
shown fluorescence staining images are confocal images, focused on the medial z-position of the respective cells, that is, the cytoplasm and the plasma membrane (A). The
different fluorochromes of secondary antibodies in the costaining of cytohesin-1 and CD18 were acquired sequentially by the use of a confocal laser scanning microscope (A).
Flow cytometric analysis shows that CCL19 (200 ng/mL for 10 minutes) strongly increases the expression of the high-affinity state (detected by mAb 327C) of LFA-1 (B). RNAi
of cytohesin-1 reduces expression of the activation epitope, compared with control cells (B). In contrast, a constitutive CD18 epitope (detected by mAb MHM23) is not altered
after RNAi of cytohesin-1 (B). The empty profiles in the flow cytometry histograms indicate the background cell stainings by isotype controls (B). RNAi of cytohesin-1 strongly
reduces static adhesion of Mo-DCs to ICAM-1-Fc compared with control cells (C). Cytohesin-1 siRNAs selectively down-regulate antigen-specific BM-DC adhesion to OT-1
T cells (D). Under flow conditions, RNAi of cytohesin-1 reduces dynamic adhesion of Mo-DCs to human umbilical vein endothelial cells (HUVECs; E) or of BM-DCs to brain
endothelioma cells (B end5; F). Overexpression of wild-type cytohesin-1 but not of the GEF-deficient E157K mutant increases static adhesion of GFP-cotransfected Mo-DCs to
ICAM-1-Fc (G). In the static adhesion assays, Mo-DCs were stimulated with 50 ng/mL PMA for 60 minutes at 37°C (C,G). Error bars indicate  SD (C-G). ***P  .001,
**P  .01, *P  .05. Each experiment was repeated at least 3 times independently. Each single experiment was performed in duplicate.
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DC adhesion in more physiological settings, we analyzed antigen-
specific adhesion of BM-DCs to transgenic OT-1 T cells, which
specifically recognize an epitope of the ovalbumin protein. Figure
2D shows that ovalbumin-loaded BM-DCs specifically adhered to
immobilized OT-1 T cells. Importantly, this antigen-specific cell-
cell interaction is abrogated if cytohesin-1 expression is selectively
silenced in the dendritic cell, suggesting that beta-2 integrin
activation on DCs contributes to DC/T-cell interactions.
Furthermore, we analyzed the interactions of Mo-DCs and
BM-DCs with endothelial cells under physiological flow condi-
tions. To this end, we first tested dynamic adhesion of mature
dendritic cells to human umbilical vein endothelial cells (HUVECs)
with the help of time-lapse video imaging using a flow chamber.
HUVECs were stimulated to express chemokines and adhesion
molecules by incubation with TNF- overnight. In addition,
CXCL12 was added, which binds to the surface of endothelial
cells. Mature DCs were then injected into the chamber at a steady
flow rate of 0.2 mL/minute (1 dyne/cm2) and subsequent DC
interactions with HUVECs were evaluated in 6 different optical
fields within 3 minutes. Adhesion to unstimulated HUVEC mono-
layers under flow was not observed (not shown). RNAi of
cytohesin-1 clearly reduced adhesion of mDCs to HUVECs under
flow compared with control cells (Figure 2E). The importance of
cytohesin-1 for the activation of DC integrins under flow condi-
tions was also confirmed for the murine system, by assessing
BM-DC adhesion to TNF-alpha–activated murine brain endothe-
lioma cells (Figure 2F). All these data are in accordance with our
earlier observation, which revealed that cytohesin-1 overexpres-
sion enhanced LFA-1–mediated arrest of leukocytes on activated
endothelium under flow.22 Finally, we assessed whether the GEF
function of cytohesin-1 is important for regulating adhesive events
of DCs. To this end, we used the novel microporation method
“Transfection of monocyte-derived DCs with plasmid DNA” to
overexpress wild-type cytohesin-1 or the GEF-deficient mutant
E157K23 together with a cotransfected plasmid that directs expres-
sion of the green fluorescent protein. Figure 2G shows that
overexpression of wild-type cytohesin-1, but not of the E157K
mutant, strongly enhances GFP-positive Mo-DC adhesion to
ICAM-1.
Taken together, we show strong and coherent evidence that
cytohesin-1—which requires an active GEF function—is an impor-
tant regulator of integrin-mediated adhesion of dendritic cells in
several systems.
DC migration strongly depends on cytohesin-1 function in vitro
and in vivo
An important hallmark of mature DCs is their ability to migrate
rapidly and directionally in chemokine gradients. To assess the
chemotaxis of Mo-DCs, we first performed so-called transwell
migration assays. To this end, transwell polycarbonate filters were
either used uncoated, or were coated with the integrin ligands
ICAM-1-Fc, fibronectin, or collagen I, respectively. RNAi of
cytohesin-1 strongly reduced CCL19- or CXCL12- (not shown)
stimulated migration of Mo-DCs in all conditions tested (Figure
3A-D). Overexpression analysis revealed that the GEF function of
the protein is also required for this function (Figure 3E). Thus, a
GEF-competent cytohesin-1 strongly regulates migration of Mo-
DCs in vitro.
We investigated whether cytohesin-1 is important for migration
of mature DCs in vivo. Using RNAi we reduced the expression of
cytohesin-1 in mature, murine bone marrow–derived DCs (BM-
DCs) to approximately 10% of endogenous levels (Figure 1C).
Control cells and cytohesin-1 knockdown cells were differentially
labeled with either CFSE or TAMRA dyes, and equal numbers of
these cell groups were subsequently injected into the hind footpad
of wild-type C57/BL6 mice.31 To exclude a perturbing effect of the
dyes themselves on in vivo migration of DCs, the labeling of the
respective populations was interchanged between experiments
(Figure 4B,C). Twenty-four to 30 hours after injection, the draining
(popliteal) lymph nodes (LNs) were extracted from these animals;
single-cell suspensions were prepared and analyzed by FACS.
Figure 4A shows that cytohesin-1 knockdown strongly reduced the
migration of mature DCs to the draining lymph node in vivo. The
numbers of BM-DCs that reached the LN were decreased by
approximately 50% compared with control BM-DCs (set to 100%
migration). Therefore, cytohesin-1 protein expression in DCs
appears highly important for efficient migration of such cells from
the tissue periphery to secondary lymphoid organs.
Cytohesin-1 selectively regulates 3D migration of
integrin-bearing DCs
Using life cell imaging microscopy, we further studied the bulk
migratory behavior of mature BM-DCs. Migration within tissues
requires coordinated interactions with constituents of the extracel-
lular matrix.32 With the help of 3D collagen type I gels as a
structural scaffold, we modeled such complex conditions and
Figure 3. RNAi of cytohesin-1 reduces chemotaxis of mature Mo-DCs. Transwell
migration assays show that CCL19 (200 ng/mL)–induced chemotaxis is overall
strongly reduced in cytohesin-1 knockdown mature Mo-DCs, using integrin ligands
ICAM-1-Fc ( 10 g/mL; A), fibronectin (50 g/mL; B), collagen I (30 g/mL; C), or
uncoated filters (D). Overexpression of wild-type cytohesin-1 but not of the GEF-
deficient E157K mutant increases chemotaxis of GFP-cotransfected Mo-DCs (un-
coated filters; E). Error bars indicate  SD. *P  .05. Each experiment was repeated
at least 3 times independently. Each single experiment was performed in duplicate.
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analyzed the migration of BM-DCs in these settings. Stimulation
with CCL19 induced vigorous and directional migration of control
DCs (Figure 5A,B and corresponding Videos S1-S4). In contrast,
RNAi of cytohesin-1 strongly impaired CCL19-stimulated migra-
tion of BM-DCs within collagen (Figure 5C and corresponding
Videos S5,S6). Using the ImageJ plug-in for manual tracking, we
detected that average migratory speed (velocity), forward migra-
tion index, and directionality of cytohesin-1 knockdown DCs were
significantly reduced compared with control cells (Figure 5E,F).
Because Lämmermann et al had shown that the inhibition of the
RhoA/myosin II pathway by blebbistatin resulted in the abrogation
of DC contractility in 3D environments,25 we opted to use RNAi of
RhoA in our assays. Strikingly, knockdown of RhoA yielded a
highly similar phenotype as that of cytohesin-1 (Figure 5D-F and
corresponding Videos S7,S8).
Lämmermann et al25 had shown that integrins are not required
for BM-DC migration in 3D environments and in vivo. Using
quadruple knockout BM-DCs, which do not express integrins on
their surfaces,25 we therefore assessed whether cytohesin-1 was
also required for integrin-independent migration of BM-DCs in 3D
collagen. Figure 5 shows that 3D migration of wild-type cells was
comparable with integrin-deficient BM-DCs, as expected (Figure
5I,K). Most interestingly, however, we found that RNAi of
cytohesin-1, which was similarly efficient in both cell types (Figure
5O), selectively affected 3D migration of integrin-bearing wild-
type cells (Figure 5J,M,N). These findings suggest an important
limiting function of cytohesin-1 in 3D leukocyte migration of
integrin-positive DCs.
Cytohesin-1 controls activation of RhoA in several cell types
The apparent involvement of cytohesin-1 in beta-2 integrin activa-
tion and in integrin-independent interstitial migration of dendritic
cells prompted us to investigate a possible and as-yet unappreciated
upstream role of cytohesin-1 in RhoA activation of dendritic cells.
Giagulli et al15 had shown that RhoA is an important regulator of
chemokine-induced T-cell adhesion to activated endothelium in
vitro and in vivo, possibly by inducing or by stabilizing the
high-affinity state of LFA-1. Rho GTPases are furthermore well
known as key regulators of cell migration. In controlling diverse
signal transduction pathways that link cell surface receptors to a
variety of intracellular responses, they influence actin filament and
microtubule dynamics, cell polarity, vesicular trafficking, and gene
expression.33 Furthermore, Rho GTPases are essential in maintain-
ing immune responses as they regulate lymphocyte and dendritic
cell function and migration.34 Rho GTPases cycle between an
active GTP-bound and an inactive GDP-bound state. The active
GTP-loaded enzyme selectively interacts with downstream effector
molecules. Activation of the GTPases was analyzed with the help
of enzyme linked immunosorbent assays (ELISAs), using immobi-
lized Rac or RhoA effector proteins PAK-1 and rhotekin, respec-
tively. We observed that RNAi of cytohesin-1 reduces GTP loading
of RhoA, whereas the activity of Rac is enhanced by cytohesin-1
knockdown in Mo-DCs (Figure 6A). Furthermore, a consistent
reduction of RhoA activity is observed upon cytohesin-1 or RhoA
protein knockdown (Figure 6B) in BM-DCs.
Significantly, the control of RhoA activity by cytohesin-1 is not
restricted to immune cells. Overexpression of wild-type cytohesin-1 in
HeLa cells results in an increase of RhoA activity, compared with the
control sample that had been transfected with the vector. The GEF
function of cytohesin-1 is required for RhoA activation through this
pathway, because overexpression of the cytohesin-1 E157K (GEF
minus) mutant23 abrogates this effect (Figure 6C). A role of cytohesin-1
function upstream of RhoA in this cell type was also confirmed by the
alternative method of effector protein pull-down and subsequent West-
ern blot analysis (Figure 6D). Consistently, Rac activity was signifi-
cantly enhanced by cytohesin-1 RNAi in HeLa cells as well
(Figure 6D).
To corroborate a full coherence of the functional activities of
RhoA and cytohesin-1 in all test systems used, we confirmed that
RNAi of RhoA also reduces a CCL19-induced activation epitope
expression of beta-2 integrins in Mo-DCs (Figure 6E). Further-
more, RhoA was found to be required for BM-DC adhesion to
endothelioma cells under physiological flow conditions (Figure
6F). Finally, overexpression of RhoA enhances adhesion of Mo-
DCs to ICAM-1-Fc, whereas the expression of the GTP-loading–
deficient mutant T19N abrogates this effect (Figure 6G).
We had previously shown that the functional activity of
cytohesin-1 in human lymphocytes is regulated by PI3-kinase–
dependent membrane recruitment of the protein.20 Consistently, we
found that CCL19-dependent membrane recruitment of cytohesin-1,
or LFA-1 activation epitope expression in Mo-DCs (Figure S10A,B),
can be blocked using the PI3 kinase inhibitor LY-294002. In
accordance with these data, inhibition of PI3-kinase in mature
BM-DCs yielded a reduced RhoA activity (Figure S10C).
Taken together, we conclude that cytohesin-1 acts upstream of
RhoA in directing integrin-dependent dendritic cell adhesion, their
migration in 3D collagen gels, and likely their migratory behavior
in inflamed tissues.
Actin polymerization and the generation of membrane
protrusions are not affected by cytohesin-1 in migrating DCs
Cell migration highly depends on actin polymerization leading to
membrane protrusions such as lamellipodia and filopodia, and is
Figure 4. RNAi of cytohesin-1 strongly reduces in vivo migration of mature
BM-DCs. Mature BM-DCs after transfection with control siRNA or cytohesin-1 siRNA
(for silencing efficiency, see Western blot analysis of cytohesin-1 expression after
RNAi of cytohesin-1, panel 1C) were labeled with 10 M TAMRA or 1 M CFSE,
respectively. Cytohesin-1 knockdown DCs (2.5  105) and control DCs (2.5  105)
were injected into the hind footpad of wild-type C57/BL6 mice. Flow cytometric
analysis of cell suspensions from the extracted draining (popliteal) lymph nodes 24 to
30 hours after injection shows that in vivo migration of cytohesin-1 knockdown
BM-DCs is strongly reduced, compared with control cells (A,B). To exclude fluoro-
chrome effects on DC migration, the staining was switched between the experi-
ments (C). Control BM-DCs are set to 100% migration (B,C). Error bars indicate
 SD. Each experiment was repeated 3 times independently.
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regulated by tight coordination of Rho GTPase activity.35,36 Be-
cause cytohesin-1 knockdown strongly impairs DC migration and
activation of RhoA, we further analyzed whether the actin network
in migrating DCs is affected by cytohesin-1. To this end, DCs were
fixed by formaldehyde within 3D collagen gels and stained with
Cy3-conjugated phalloidin. Mature DCs transfected with control
siRNA show F-actin at the cell cortex and within membrane
protrusions (Figure 7A). Mature DCs lack stress fibers, which is
known to be characteristic for leukocytes.37 The same, unaltered
phenotype can be detected when cytohesin-1 expression in DCs is
repressed by RNAi (Figure 7A). Thus, cytohesin-1 does apparently
not affect polymerization and arrangement of actin fibers in
membrane protrusions. Similarly, RNAi of RhoA does not influ-
ence the integrity of the peripheral actin network in mature DCs
(Figure 7B), whereas, in contrast, RNAi of Rac1 completely
inhibits generation of actin-based membrane protrusions (Figure
7C). These results are in good accordance with the recently
published paper by Lämmermann et al,25 who showed that RhoA
does not regulate the front of migrating DCs, but that the small
GTPase instead controls contractility of the cell body, which is
important for flexible cell shape changes during DC migration in
tissue environments.
Discussion
In this study, we have described an important role of the guanine
nucleotide exchange factor cytohesin-1 in the regulation of cellular
processes, as well as signaling pathways, which affect the regula-
tion of adhesion and migration of human and murine dendritic
cells. Overexpression analyses had implicated cytohesin-1 early on
in the activation of the beta-2 integrin LFA-1 in T cells.19 We show
here that cytohesin-1 expression in dendritic cells, which were
derived from primary monocytes, is required for beta-2 integrin
adhesion under static and under dynamic flow conditions, as well
as for chemokine-dependent conformational activation of this
adhesion receptor. Furthermore, we discovered an entirely novel
function of cytohesin-1 in controlling interstitial migration of
integrin-bearing DCs, but not of integrin-depleted DCs. The
signaling pathway discriminating between the 2 conditions has
been identified as well: cytohesin-1 acts upstream of the GTPase
RhoA, and this novel signaling axis is required for integrin-
mediated functions in the regulation of immune cell adhesion and
migration.
Figure 5. RNAi of cytohesin-1 strongly reduces chemotaxis of mature integrin(/) but not of integrin(/) BM-DCs in 3-dimensional collagen. Using 3D collagen
type I gels, we analyzed the role of cytohesin-1 in BM-DC complex matrix migration. Quantification of time series after live cell imaging shows that directionality, y-forward
migration index, and velocity of cytohesin-1 knockdown cells toward the chemokine CCL19 are strongly reduced (C,E,F). RNAi of RhoA results in a highly similar
phenotype (D-F). Respective silencing efficiencies are shown by Western blot analysis (G,H). Quantification of 3D migration of integrin-deficient BM-DCs shows that
directionality, y-forward migration index, and velocity of cytohesin-1 knockdown cells toward the chemokine CCL19 are strongly reduced in wild-type, that is, integrin(/)
BM-DCs (J,M,N) but not in integrin(/) BM-DCs (L-N). Efficiency of cytohesin-1 RNAi was comparable in both cell types, as shown by Western blot analysis (O). For every
3D migration experiment, the tracks of 60 individual cells were monitored over a period of 3 hours by capturing digital images every 5 minutes. Cell directionality, forward
migration index, and velocity were calculated and visualized as plots (A-D, I-L) and animated plots (Videos S1-S8) by analyzing the acquired data with the Chemotaxis and
Migration tool plug-in (Ibidi) for ImageJ. Error bars indicate  SD. ***P  .001; ns indicates not significant. The data are representative for 3 independent experiments.
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Beta-2 integrin activation by chemokines is a complex process
that involves the regulation of conformational equilibria of these
proteins.28 At least 3 conformations have been reported: resting
(none or very little ligand binding), and intermediate and high
affinity for ligand. Dendritic cells had been reported earlier to be
much more restricted in beta-2 integrin activation than other
leukocytes under certain conditions, but these studies had not used
chemokine-dependent triggering or physiological flow conditions
to test for integrin activation of DCs. Woolf et al38 had shown that
immobilized chemokines and flow forces are important require-
ments for the activation of circulating as well as migrating
leukocytes, even if these cells migrate in lymph nodes. Our novel
data reveal that integrins of mature DCs are capable of adhering to
activated endothelia under physiological flow conditions in a
cytohesin-1–dependent fashion. Apparently, beta-2 integrins of
mature human dendritic cells respond normally to such stimuli,
which is in full accordance with the aforementioned study.
The precise sequence of events of chemokine-mediated integrin
activation during physiological responses is not known, but forces
imposed by the blood flow apparently play an important role as
well as protein binding events at the cytoplasmic tails of integrins.
Cytohesin-1 had been shown to bind to the membrane-proximal
region of the beta-2 integrin cytoplasmic tail, and this is required
for adhesion and activation epitope expression. Importantly, the
ARF-GEF function is not required for integrin activation, but was
found to be important for adhesion and spreading.23 RhoA is a
small GTPase that links integrin signaling to actin cytoskeletal
rearrangements in many cell types. By use of blocking peptides,
Giagulli et al15 had found that RhoA is required for leukocyte
beta-2 integrin activation in endothelial arrest. These findings were
recently confirmed and extended by Pasvolsky et al,39 who showed
that RhoA blocking peptides regulate intermediate affinity epitope
expression of LFA-1 in T cells in flow. We now show that
cytohesin-1 regulates the GTP loading of RhoA in leukocytes and
we consistently report that both cytohesin-1 and RhoA mediate
chemokine-induced activation epitope expression of CD18 in
dendritic cells (Figure 2, Figure 6E, and data not shown). This
places cytohesin-1 upstream of RhoA in beta-2 integrin activation.
It is important to note here that this does not rule at all against an
additional direct role of cytohesin-1/CD18 interactions in LFA-1 activa-
tion.23 Taken together, our novel data reveal a signaling link between
cytohesin-1 and RhoA in beta-2 integrin activation and adhesion of
dendritic cells, which likely reflects a dual role of cytohesin-1 in integrin
binding and in downstream signaling to RhoA.
Figure 6. Cytohesin-1 controls the activity of RhoA in several cell types. RhoA is an important regulator of beta-2 integrin activation epitope expression and adhesion of
DCs. Using a commercial enzyme linked assay (ELISA), we could show that in Mo-DCs the activity (GTP loading) of the small GTPase RhoA is strongly reduced in cytohesin-1
knockdown cells, compared with control cells. As a positive control for the assay, RhoA activity of RhoA knockdown Mo-DCs was analyzed, which also shows the expected
reduction of RhoA activity. The same system was used to measure Rac activity, where RNAi of cytohesin-1 results in an increase of GTP loading (A). Consistently, RhoA activity
of RhoA knockdown BM-DCs was also found reduced (B). Overexpression of wild-type cytohesin-1 in EGF-stimulated (50 nM, 1 hour) HeLa cells results in an increase of RhoA
activity, compared with the vector control. In contrast, overexpression of the cytohesin-1 E157K mutant results in reduced RhoA activity (C). Cytohesin-1 knockdown
down-regulates RhoA activity, but up-regulates GTP loading of Rac1 in EGF-stimulated HeLa (50 nM; 1 hour) cells, as detected by effector protein pull-down and Western blot
analysis (panel D bottom panels). Knockdown of RhoA specifically reduces expression of the CD18 327C epitope in Mo-DCs (E) or adhesion under flow of BM-DCs to brain
endothelioma (B end5) cells (F). Overexpression of wild-type RhoA but not of the GTP-loading mutant T19N increases static adhesion of GFP-cotransfected Mo-DCs to
ICAM-1-Fc (G). In the static adhesion assay, Mo-DCs were stimulated with 50 ng/mL PMA for 60 minutes at 37°C (G). Error bars indicate  SD. ***P  .001, **P  .01,
*P  .05. Each experiment was repeated at least 3 times independently. Each single experiment was performed in duplicate.
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We show further and for the first time that cytohesin-1 is
required for migration of BM-DCs to lymph nodes in vivo and for
directional migration of BM-DCs in 3D collagen gels in vitro.
RhoA had been implicated in both functions. In fact, RNAi of
RhoA or cytohesin-1 resulted in a highly similar phenotype in
interstitial migration of DCs in our assay systems. Specific
treatment of BM-DCs with RhoA or cytohesin-1 siRNA yielded a
strong abrogation of chemokine-gradient direction sensing and
migratory persistence (track length). Most strikingly, however, our
analyses show that 3D migration of leukocytes in the presence or
absence of integrins is phenotypically similar but not identical.
Whereas integrin-positive cells specifically require the cytohesin-1/
RhoA signaling axis, integrin-null DCs require RhoA,25 but not
cytohesin-1 (shown in this study) for 3D motility. It thus becomes
apparent that leukocyte migration in 3D environments may also be
subclassified into different types or “modes,” reminiscent of what
has been described for certain tumor cells.40,41 The fact that
cytohesin-1 dependency discriminates between leukocytes migrat-
ing in the absence and presence of integrins raises the question how
the Rho pathway is regulated when both integrins and cytohesin-1
are absent and why this alternative pathway is not used when only
cytohesin-1 is missing? One likely possibility is that in the absence
of integrins, DCs use another migratory mode that does not depend
on cytohesin as a Rho activator. This would imply that DCs can use
phenotypically identical but molecularly distinct migratory strate-
gies and suggest that there is more plasticity within the ameboid
migration mode than expected. In these experiments, we have used
cells that lack all surface integrins to elucidate a principal role of
cytohesin-1 in 3D immune cell migration. Consistent with all of
our earlier findings, we furthermore show a strong functional
association of this protein with beta-2 integrins. However, these
data do not exclude a possible cooperation of cytohesin-1 with
other integrins in these functions.
How are cytohesin-1 functions linked to RhoA signaling?
Cytohesin-1 is a guanine nucleotide exchange factor for ARF-
GTPases, and GDP/GTP exchange activities for other GTPases
have never been reported. It is important to note here that a large
body of work implicates cytohesin-2 (or ARNO) and -3 (Grp1) in
ARF6 signaling upstream of Rac-1.42 Cytohesin-1 has never been
implicated in direct activation of the endosomal and cytoskeletal
signaling GTPase ARF6. In fact, data from our laboratory rule
against such a link in T cells.43 RhoA and Rac activity are tightly
coordinated in cell migration and are often controlled in a
reciprocal fashion.44-46 Interestingly, we observed not only a
down-regulation of RhoA activity by cytohesin-1 knockdown but
an up-regulation of Rac activity as well. This indicates that the
control of Rho GTPase activities by cytohesins in immune and
nonimmune cells might be aspects of a common theme, involving
specific roles of cytohesin-1 in the RhoA pathway and of cytohesin-
2/3 in Rac signaling.
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Figure 7. Cytohesin-1 is not involved in the formation of membrane protru-
sions. Microscopic visualization of F-actin by the use of Cy3-phalloidin shows that
the formation of membrane protrusions in mature Mo-DCs is not influenced by RNAi
of cytohesin-1, compared with control cells (A). RNAi of RhoA also shows the same
unaltered phenotype (B), whereas RNAi of Rac1 results in strong deficiencies in the
formation of membrane protrusions (C). Quantification of membrane protrusions
shows that after RNAi of cytohesin-1 respective RhoA 70% of all mature Mo-DCs
have lamellipodia and do not differ from control cells (A,B). In contrast, RNAi of Rac
reduces formation of lamellipodia approximately 50% (C). Bars represent 5 m. In
each individual experiment, 200 mature DCs were counted. Each single experiment
was performed in duplicate. Error bars indicate  SD. *P  .05. Each experiment
was repeated at least 3 times independently.
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